In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-12
DOI
10.1038/s41380-021-01431-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?
- (2021) Ramachandran Vignesh et al. Frontiers in Immunology
- How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry
- (2021) Drozdstoy Stoyanov et al. World Journal of Psychiatry
- Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent
- (2021) Aliye Bastug et al. RHEUMATOLOGY INTERNATIONAL
- HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism
- (2021) Hayrunnisa Bolay et al. JOURNAL OF HEADACHE AND PAIN
- SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
- (2021) Pan Pan et al. Nature Communications
- Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19
- (2021) Alessandra Oliva et al. Frontiers in Immunology
- Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients
- (2021) Hongliang Zhang et al. Frontiers in Molecular Biosciences
- CT Imaging and Differential Diagnosis of COVID-19
- (2020) Wei-cai Dai et al. CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
- Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma
- (2020) Chi-Jung Chung et al. Scientific Reports
- Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19
- (2020) Adnan Shah Frontiers in Immunology
- Brain control of appetite during sickness
- (2020) Gabriella Aviello et al. BRITISH JOURNAL OF PHARMACOLOGY
- Reconciling protective and pathogenic roles of the NLRP3 inflammasome in leishmaniasis
- (2020) Valerie Harrington et al. IMMUNOLOGICAL REVIEWS
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Targeting the NLRP3 Inflammasome in Severe COVID-19
- (2020) Tracey L. Freeman et al. Frontiers in Immunology
- Mechanisms of NLRP3 priming in inflammaging and age related diseases
- (2020) Anna Gritsenko et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- (2020) Takehiro Takahashi et al. NATURE
- How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia
- (2020) Michael Maes et al. Brain Sciences
- COVID-19 stokes inflammasomes
- (2020) Clare Bryant JOURNAL OF EXPERIMENTAL MEDICINE
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes
- (2020) Pritam Sadhukhan et al. Cancers
- Immune-inflammatory, oxidative stress and biochemical biomarkers predict short-term acute ischemic stroke death
- (2019) Edna Maria Vissoci Reiche et al. METABOLIC BRAIN DISEASE
- CAPS and NLRP3
- (2019) Laela M. Booshehri et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
- (2019) Erin Fahey et al. Frontiers in Immunology
- NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
- (2019) Zhaofei Wan et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Blood Glucose Levels and Mortality in Patients With Sepsis: Dose–Response Analysis of Observational Studies
- (2019) Wen Wang et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Role of NLRP-3 Inflammasome in Hypertension: a Potential Therapeutic Target
- (2018) Teresa Pasqua et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review
- (2017) Jakeline Rheinheimer et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome
- (2016) Zi-Teng Zhang et al. Journal of Neuroinflammation
- NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis
- (2016) Shigehiro Itani et al. Scientific Reports
- Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
- (2014) Holger K. Eltzschig et al. NATURE REVIEWS DRUG DISCOVERY
- A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior
- (2013) Gerwyn Morris et al. BMC Medicine
- Variants of NLRP3 gene are associated with insulin resistance in Chinese Han population with type-2 diabetes
- (2013) Yingying Zheng et al. GENE
- Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
- (2013) Kurt Lucas et al. MOLECULAR NEUROBIOLOGY
- Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
- (2013) Ryan W. Grant et al. Frontiers in Immunology
- Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
- (2012) Michael Maes et al. BMC Medicine
- Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
- (2012) Vishwa Deep Dixit DIABETES
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Mechanism of Interleukin-1β Induced-Increase in Mouse Intestinal Permeability In Vivo
- (2012) Rana Al-Sadi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now